Medico Intercon.

Medico_Intercon.30 Apr 2024

Trading

₹

-0.89 (-1.98%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Medico Intercon.

Medico Intercon.

Trading

Medico_Intercon.30 Apr 2024

₹

-0.89 (-1.98%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2023	D	Board Recommended a final dividend of Rs. 0.10/- per equity share of the face value of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval by the shareholders at their 39th Annual General Meeting. The Dividend, if approved by the Shareholders will be paid on or after 5th July, 2023.	23-Jun-2023
25-Apr-2024	BC	Intimation of Resignation of Mr. Nikul D Shah, Independent Director of the Company.	25-Apr-2024
09-Apr-2024	BC	Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting hel	09-Apr-2024
29-May-2023	BC	Re-appointment of Mr. Ankur Amiram Dave as an Independent Director of the Company for the second term of 5 years w.e.f. 24th March, 2024 subject to approval by the shareholders at their 39th Annual	24-Mar-2024
06-Feb-2024	BC	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve The meeting of the Board of Directo	14-Feb-2024
25-Nov-2023	BC	Samir Dilipkumar Shah	24-Nov-2023

No Rights has been declared by Medico_Intercon.

Book Closure

Record Date	Split Date	Purpose
25-Apr-2024	-	Intimation of Resignation of Mr. Nikul D Shah, Independent Director of the Company.
09-Apr-2024	-	Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting hel
24-Mar-2024	-	Re-appointment of Mr. Ankur Amiram Dave as an Independent Director of the Company for the second term of 5 years w.e.f. 24th March, 2024 subject to approval by the shareholders at their 39th Annual
14-Feb-2024	-	Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve The meeting of the Board of Directo
24-Nov-2023	-	Samir Dilipkumar Shah

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Medico Intercontinental Ltd ₹44.05(-0.89/-1.98%)	44.05	-0.89	44.05	-48.87	21.81	1.25
Computer Point Ltd ₹4.63(-0.11/-2.32%)	4.63	-0.11	13.89	125.71	463.00	0.42
Ambalal Sarabhai Enterprises Ltd ₹46.40(-0.15/-0.32%)	46.40	-0.15	355.58	107.26	0.00	9.77
Novartis India Ltd ₹1,035.05(-17.45/-1.66%)	1,035.05	-17.45	2,555.62	77.19	26.75	3.64
Aegis Logistics Ltd ₹686.30(-11.35/-1.63%)	686.30	-11.35	24,089.13	77.00	54.60	10.85
Modella Woollens Ltd ₹72.00(-0.02/-0.03%)	72.00	-0.02	6.55	2.86	0.00	-71.29

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	7.33	9.81	16.90	22.57	12.01	8.13
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	7.33	9.81	16.90	22.57	12.01	8.13
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.08	0.24	0.06	0.17	0.15	0.00
Total Income	7.41	10.05	16.96	22.73	12.16	8.13
Total Expenditure	6.64	9.33	16.21	21.80	11.58	7.48
PBIDT	0.76	0.72	0.75	0.93	0.59	0.66
Interest	0.07	0.02	0.05	0.03	0.06	0.14
PBDT	0.70	0.70	0.70	0.90	0.53	0.52
Depreciation	0.05	0.05	0.04	0.03	0.02	0.02
Tax	0.18	0.19	0.18	0.30	0.13	0.13
Deferred Tax	-0.01	-0.01	-0.01	-0.01	0.00	0.00
Reported Profit After Tax	0.48	0.48	0.48	0.58	0.38	0.37
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.48	0.48	0.48	0.58	0.38	0.37

EPS (Unit Curr.)	0.48	0.48	0.48	0.58	0.41	1.14
EPS (Adj) (Unit Curr.)	0.48	0.48	0.48	0.58	0.41	1.14
Calculated EPS (Unit Curr.)	0.48	0.48	0.48	0.58	0.38	1.14
Calculated EPS (Adj) (Unit Curr.)	0.48	0.48	0.48	0.58	0.38	1.14
Calculated EPS (Ann.) (Unit Curr.)	1.90	1.91	1.92	2.34	1.51	4.58
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.90	1.91	1.92	2.34	1.51	4.58
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.00	10.00	10.00	10.00	10.00	3.25
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	10.37	7.34	4.44	4.12	4.91	8.12
PBDTM(%)	9.55	7.14	4.14	3.99	4.41	6.40
PATM(%)	6.55	4.89	2.84	2.57	3.16	4.55

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	14.25	17.12	24.28	29.01	18.07	16.26
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	14.25	17.12	24.28	29.01	18.07	16.26
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.09	0.08	0.08	0.26	0.22	0.00
Total Income	14.34	17.21	24.36	29.27	18.28	16.26
Total Expenditure	12.77	15.81	22.80	27.66	16.95	14.84
PBIDT	1.57	1.40	1.56	1.61	1.33	1.42
Interest	0.13	0.09	0.11	0.10	0.12	0.20
PBDT	1.45	1.30	1.45	1.51	1.21	1.22
Depreciation	0.07	0.07	0.07	0.06	0.05	0.05
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.37	0.37	0.37	0.46	0.30	0.31
Deferred Tax	-0.01	-0.01	-0.01	-0.02	0.00	0.00
Reported Profit After Tax	1.02	0.87	1.02	1.01	0.87	0.86
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	1.02	0.87	1.02	1.01	0.87	0.86

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.02	0.87	1.02	1.01	0.87	0.86

EPS (Unit Curr.)	1.02	0.87	1.02	1.01	0.94	2.66
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.00	10.00	10.00	10.00	10.00	3.25

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	11.02	8.18	6.43	5.55	7.36	8.73
PBDTM(%)	10.18	7.59	5.97	5.21	6.70	7.50
PATM(%)	7.16	5.08	4.20	3.48	4.81	5.29

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.00	3.25	3.25	3.25	3.25	3.25
Reserves Total	24.30	4.40	3.09	1.90	0.78	0.02
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	34.30	7.65	6.34	5.15	4.03	3.27
Secured Loans	2.23	5.44	3.34	6.59	0.00	0.00
Unsecured Loans	0.04	0.77	1.47	1.97	0.09	0.02
Total Debt	2.27	6.21	4.81	8.56	0.09	0.02
Total Liabilities	36.57	13.86	11.15	13.71	4.12	3.29
APPLICATION OF FUNDS :
Gross Block	0.76	0.40	0.34	0.15	0.01	0.01
Less : Accumulated Depreciation	0.29	0.20	0.09	0.03	0.01	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.47	0.20	0.25	0.12	0.00	0.01
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	4.20	4.20	4.35	3.57	0.03	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.69	2.47	3.56	2.56	0.63	0.00
Sundry Debtors	24.92	8.48	8.03	12.67	6.47	1.33
Cash and Bank	4.95	1.29	0.12	0.14	1.15	0.16
Loans and Advances	0.19	0.11	0.10	0.11	0.04	0.00
Total Current Assets	33.75	12.34	11.81	15.47	8.29	1.50
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7.60	3.74	5.05	5.26	4.94	0.61
Provisions	0.15	0.12	0.21	0.22	0.06	0.01
Total Current Liabilities	7.76	3.85	5.26	5.47	5.00	0.62
Net Current Assets	25.99	8.48	6.54	10.00	3.29	0.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.05	0.03	0.02	0.01	0.01	0.02
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.05	0.03	0.02	0.01	0.01	0.02
Total Assets	30.72	12.91	11.15	13.70	3.33	0.91
Contingent Liabilities	4.51	4.51	0.00	0.00	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.00	3.25	3.25	3.25	3.25	3.25
Reserves Total	31.19	9.39	6.29	3.11	0.75	0.02
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	41.19	12.64	9.54	6.36	4.00	3.27
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	4.40	7.58	6.16	8.38	0.00	0.00
Unsecured Loans	0.32	1.15	3.15	5.28	0.11	0.02
Total Debt	4.72	8.73	9.31	13.66	0.11	0.02
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.11	0.00	0.00	0.00	0.00	0.00
Total Liabilities	46.02	21.37	18.85	20.02	4.11	3.29
APPLICATION OF FUNDS :
Gross Block	4.04	3.62	3.41	2.61	0.01	0.01
Less: Accumulated Depreciation	1.47	1.27	1.06	0.92	0.01	0.00
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	2.57	2.35	2.35	1.69	0.00	0.01
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.02	0.01	0.16	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	8.88	7.88	9.11	8.68	0.63	0.00
Sundry Debtors	32.85	17.14	17.98	22.77	6.47	1.33
Cash and Bank	6.79	1.87	0.51	0.78	1.18	0.16
Loans and Advances	1.19	1.36	0.52	1.80	0.04	0.00
Total Current Assets	49.71	28.25	28.12	34.03	8.32	1.50
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	12.22	9.97	11.18	15.44	4.95	0.61
Provisions	0.64	0.57	0.59	0.56	0.06	0.01
Total Current Liabilities	12.86	10.54	11.78	16.00	5.01	0.62
Net Current Assets	36.84	17.71	16.34	18.02	3.31	0.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.07	0.03	0.02	0.01	0.01	0.02
Deferred Tax Liability	0.05	0.04	0.04	0.03	0.00	0.00
Net Deferred Tax	0.02	-0.01	-0.02	-0.02	0.01	0.02
Other Assets	6.56	1.31	0.01	0.34	0.79	2.39
Total Assets
Contingent Liabilities	4.51	4.51	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.29	0.12	0.14	1.15	0.16
Net Cash from Operating Activities	-11.95	1.10	5.44	-6.55	0.95
Net Cash Used In Investing Activities	-5.02	-0.80	-0.94	-3.68	-0.03
Net Cash Used In Financing Activities	20.63	0.87	-4.51	9.22	0.07
Net Inc./Dec In Cash And Cash Equivalents	3.66	1.17	-0.02	-1.01	0.99
Cash And Cash Equivalents At End Of The Year	4.95	1.29	0.12	0.14	1.15

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

55.08%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

44.92%

**Promoter pledged shareholding 55.08%

About Medico Intercontinental Ltd

Medico Intercontinental Ltd is in the Trading sector, having a market capitalization of Rs. 44.05 crores. It has reported a sales of Rs. 7.33 crores and a net profit of Rs. 0.48 crores for the quarter ended December 2018. The company management includes Tanvi Shah, Samir Shah,Tanvi Shah,Swati Vikramkumar Shah,Funeeta Sharma,Ankur Amiram Dave,Nikul Dipakbhai shah,Priyank Lalitbhai Sancheti (Medico Intercontinental Ltd) among others.

Chairman

Tanvi Shah

Registered office

213 2nd Floor,Raheja Chambers Nariman Point,Mumbai,Maharashtra,400021

FAX :

Background

Incorporation Year1984

Face Value₹10

Market Lot1

How to buy Medico Intercon. shares on nse?

To buy Medico Intercon. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Medico Intercon. share price today?

The Medico Intercon. shares price on nse is Rs.44.05 today.

What is the market cap of Medico Intercon. shares on BSE ?

The company has a market capitalization of Rs.44.05Cr

What is the PE & PB ratio of Medico Intercon. shares ?

PE is 21.81 and PB is 1.25

What is the 52 Week High and Low of Medico Intercon. shares?

Medico Intercon. stock price high: Rs.122 Medico Intercon. stock price low: Rs.39